EZZ Life Science Holdings Limited (ASX:EZZ)

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Company Owned	63.21M	62.57M	32.54M	8.14M	11.37M
Company Owned Growth	1.02%	92.29%	299.83%	-28.41%	1392.96%
Brought in Lines	3.66M	3.87M	4.60M	6.88M	10.92M
Brought in Lines Growth	-5.39%	-15.94%	-33.14%	-36.96%	-34.04%
Total	66.87M	66.44M	37.14M	15.02M	22.29M
Total Growth	0.65%	78.88%	147.26%	-32.60%	28.71%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Australia and New Zealand	8.39M	11.24M	9.76M	9.43M	12.01M
Australia and New Zealand Growth	-25.40%	15.21%	3.45%	-21.43%	-19.46%
Mainland China	44.19M	52.43M	26.80M	4.35M	10.13M
Mainland China Growth	-15.72%	95.65%	516.15%	-57.06%	325.03%
Other Countries/Regions	-	16.77K	585.35K	1.24M	150.34K
Other Countries/Regions Growth	-	-97.13%	-52.75%	723.95%	532.18%
South-East Asia	14.30M	2.75M	-	-	-
South-East Asia Growth	419.80%	-	-	-	-
Total	66.87M	66.44M	37.14M	15.02M	22.29M
Total Growth	0.65%	78.88%	147.26%	-32.60%	28.71%

Source: S&P Global Market Intelligence.